Xenetic Biosciences, Inc. ( XBIO) - Key Metrics
XBIO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $0.33 | -$0.25 | -$0.11 | -$0.11 |
| 2025Q3 | $0.67 | -$0.33 | -$0.43 | -$0.43 |
| 2025Q2 | $0.38 | -$0.45 | -$0.25 | -$0.25 |
| 2025Q1 | $0.38 | -$0.59 | -$0.65 | -$0.65 |
| 2024Q4 | $0.42 | -$0.68 | -$0.44 | -$0.44 |
XBIO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | -2.15 |
| 2025Q3 | ? | -2.37 |
| 2025Q2 | ? | -2.19 |
| 2025Q1 | ? | -1.11 |
| 2024Q4 | ? | -1.46 |
XBIO
Price: $3.42
52 week price:
Earnings Per Share: -1.58 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 27600
Ebitda: -8.4 millionMarket Capitalization: 5.3 million